Angelucci Group Acquires Nomentana Hospital

The Italian healthcare sector sees a significant consolidation as San Raffaele spa, a private healthcare provider linked to Senator Antonio Angelucci and controlled by the holding company Tosinvest, has finalized the acquisition of the entire business complex of Nomentana Hospital. This acquisition was executed through a negotiated settlement procedure, marking a pivotal moment for the Lazio region's private healthcare infrastructure. The transaction, which saw PwC advising the seller, injects new capital into a facility facing financial challenges.

Nomentana Hospital, established in 1954 and situated in Fonte Nuova, near Rome, stands as the largest accredited private clinic in the Lazio region. It boasts a substantial capacity of over 550 beds, supported by a dedicated team of approximately 100 highly specialized physicians, 150 physiotherapists, and 200 nurses. The facility offers a broad spectrum of services, including rehabilitation (110 beds), long-term care (98 beds), residential care for varying levels of dependency (186 beds), outpatient dialysis, hospice care, and specialized centers. According to the Lazio region's 2024-2026 hospital network plan, the facility is allocated 208 beds, with approximately 90% of its funding originating from the regional government and employing around 500 staff members.

The operational transfer has been streamlined through a newly established entity, Nuova Nomentana Hospital srl. This new company has secured the necessary operational permits and institutional accreditation from the Regione Lazio, confirmed through directives issued in February-March 2026. This regulatory approval ensures a seamless transition and the continuation of services, with the 2026 budget being appropriately divided between the outgoing and incoming entities. Antonio Vallone is listed as the new legal representative for the facility.

The origins of Nomentana Hospital trace back to the Berloco family and their management through Centro di Sanità spa. Even in 2013, when Centro di Sanità spa was in liquidation, an authorization transfer to Nomentana Hospital srl was approved following the contribution of the healthcare business. Subsequently, Nomentana Hospital srl absorbed the liquidating entity, consolidating the business operations.

However, recent years presented considerable difficulties for the hospital. By 2020, the company had to resort to social safety nets, including temporary layoffs for 250 employees. The formal initiation of the negotiated settlement procedure in April 2024, with the appointment of Gianluca Piredda as the expert mediator, highlighted the severity of the situation. Union representatives from CGIL, CISL, and UIL had previously voiced concerns over prolonged salary payment uncertainties. The financial strain culminated in a December 2024 announcement by the board of directors regarding a liquidity crisis, jeopardizing the payment of year-end bonuses for the approximately 500 employees. The expert's assessment ultimately concluded that a turnaround was not feasible without a new industrial plan, leading to the decision to pursue a sale.

This acquisition by San Raffaele spa, part of the broader Tosinvest group, underscores a trend of consolidation within Italy's private healthcare sector. The deal aims to stabilize and potentially enhance the operational capacity of Nomentana Hospital, ensuring the continuity of essential healthcare services for the region. The healthcare industry in Italy, particularly private accredited facilities, often navigates complex regulatory environments and funding models, making strategic acquisitions crucial for long-term viability and growth.